328 related articles for article (PubMed ID: 2157251)
1. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
3. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.
Trejtnar F; Laznicek M; Laznickova A
Nucl Med Biol; 2003 Jan; 30(1):45-9. PubMed ID: 12493542
[TBL] [Abstract][Full Text] [Related]
5. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
Taylor A; Eshima D
J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of technetium-99m-MAG3 in humans.
Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m (99mTc) mercaptoacetyltriglycine: update on the new 99mTc renal tubular function agent.
Eshima D; Taylor A
Semin Nucl Med; 1992 Apr; 22(2):61-73. PubMed ID: 1534184
[TBL] [Abstract][Full Text] [Related]
9. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
[TBL] [Abstract][Full Text] [Related]
11. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
[TBL] [Abstract][Full Text] [Related]
14. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
Stabin M; Taylor A; Eshima D; Wooter W
J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
Taylor A; Corrigan P; Eshima D; Folks R
J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
[TBL] [Abstract][Full Text] [Related]
16. [Clinical assessment of 99mTc-MAG3 scintigraphy for impaired renal function].
Sato M; Hirayama K; Ishikawa N; Takeda T; Wu J; Itai Y; Kobayashi M; Koyama A
Kaku Igaku; 1994 Jan; 31(1):75-84. PubMed ID: 8309113
[TBL] [Abstract][Full Text] [Related]
17. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
[TBL] [Abstract][Full Text] [Related]
18. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A
Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
[TBL] [Abstract][Full Text] [Related]
20. Measurements of 99mTc-MAG3 uptake in renal transplant recipients.
Oei HY; Surachno S; Wilmink JM; van der Schoot JB
Contrib Nephrol; 1990; 79():113-7. PubMed ID: 2146080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
